SCHEMBL6182985

SCHEMBL6182985

O=C(c1cc(-c2ccc(Cl)cc2)nc2ccc(OC(F)(F)F)cc12)N1CCC(N2CCC[C@@H](C(=O)N3CCOCC3)C2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOK Q9UQ07 3/20 0.48
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
GAA P10253 2/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 2/20 0.48
ACACB O00763 1/20 0.48
ACACA Q13085 1/20 0.48
DHODH Q02127 1/20 0.47
POLB P06746 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ATM Q13315 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
CYP2C9 P11712 2/20 0.43
LMNA P02545 3/20 0.43
TSHR P16473 2/20 0.43
TRPV1 Q8NER1 1/20 0.42
USP2 O75604 1/20 0.42
TP53 P04637 1/20 0.42
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6183582 0.88 ACACB (0.52) MOKALDH1A1KDM4EGAAHPGD
SCHEMBL6183490 0.87 ALDH1A1 (0.58) MOKALDH1A1KDM4EGAAHPGD
SCHEMBL6184192 0.85 ACACB (0.51) MOKALDH1A1KDM4EGAAHPGD
SCHEMBL6183549 0.85 ACACB (0.53) MOKALDH1A1KDM4EGAAHPGD
SCHEMBL977857 0.83 ACACB (0.51) MOKALDH1A1KDM4EGAAHPGD
SCHEMBL6185309 0.80 ACACB (0.53) MOKALDH1A1KDM4EGAAHPGD
SCHEMBL6181722 0.80 ACACB (0.51) MOKALDH1A1KDM4EGAAHPGD
SCHEMBL6180226 0.79 ACACB (0.58) GAAACACBACACALMNA
SCHEMBL6182565 0.76 ACACB (0.55) MOKALDH1A1KDM4EGAAHPGD
SCHEMBL6184827 0.76 ACACB (0.55) MOKALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6979741-B2 Acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2005-12-27 US disclosed
EP-1478437-B1 ACC INHIBITORS PFIZER PROD INC (US) 2005-08-31 EP disclosed
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors PFIZER INC. 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors ACACA, ACACB, ACAT1 MOK 2054/4885ALDH1A1 654/4885KDM4E 2140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.